KIA
MRNA icon

Kraematon Investment Advisors’s Moderna MRNA Stock Holding History

Kraematon Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,671
Closed -$203K – 84
2023
Q2 		$203K Hold
1,671
– – 0.22% 84
2023
Q1 		$257K Hold
1,671
– – 0.3% 70
2022
Q4 		$300K Buy
+1,671
New +$273K 0.33% 65
2022
Q3 		– Sell
-1,671
Closed -$239K – 83
2022
Q2 		$239K Hold
1,671
– – 0.28% 74
2022
Q1 		$288K Hold
1,671
– – 0.27% 77
2021
Q4 		$424K Buy
+1,671
New +$489K 0.38% 63

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Kraematon Investment Advisors's MRNA Position: Q3 2023 in Review

Kraematon Investment Advisors sold out of Moderna (MRNA) in Q3 2023, closing a stake of 1,671 shares — an estimated $203K sold.

Kraematon Investment Advisors first reported a position in MRNA in Q4 2021 and held it in 6 quarters. The position peaked at $424K in Q4 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Kraematon Investment Advisors reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Kraematon Investment Advisors sold 1,671 Moderna shares in Q3 2023, an estimated $203K.
  • Kraematon Investment Advisors first reported a position in Moderna in Q4 2021 and held it in 6 quarters.
  • Kraematon Investment Advisors's Moderna position peaked at $424K in Q4 2021.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Kraematon Investment Advisors's 13F filing for Q3 2023, filed 1 Nov 2023.